Zura Bio (ZURA) Revenue & Revenue Breakdown
Zura Bio Revenue Highlights
00
Zura Bio Revenue by Period
Zura Bio Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | - |
Zura Bio generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Zura Bio Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $2.00K | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | - |
Zura Bio generated - in revenue during Q1 2025, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Zura Bio Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| TRDA | Entrada Therapeutics | $210.78M | $20.56M |
| ENTA | Enanta Pharmaceuticals | $67.64M | $18.31M |
| GNFT | Genfit | $28.57M | $17.08M |
| FHTX | Foghorn Therapeutics | $22.60M | $7.56M |
| NTHI | Neonc Technologies | $83.00K | - |
| IMRX | Immuneering | - | - |
| ZURA | Zura Bio | - | - |
| SLS | SELLAS Life Sciences Group | - | - |
| CRBU | Caribou Biosciences | - | - |
| ASMB | Assembly Biosciences | - | $9.42M |
| SGMT | Sagimet Biosciences | - | - |